https://orcid.org/0000-0001-5521-9315
References
- Burge PS. Sick building syndrome. Occup Environ Med. 2004;61(2):185–190. doi:10.1136/oem.2003.008813
- Editorial. Sick building syndrome. Lancet. 1991;338(8781):1493–1494. doi:10.1016/0140-6736(91)92305-L
- Saeki Y, Kadonosono K, Uchio E. Clinical and allergological analysis of ocular manifestations of sick building syndrome. Clin Ophthalmol. 2017;11:517–522. doi:10.2147/OPTH.S124500
- Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy. 2000;30(1):103–109. doi:10.1046/j.1365-2222.2000.00699.x
- Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992;90(4):1479–1485. doi:10.1172/JCI116015
- Matsuura N, Uchio E, Nakazawa M, et al. Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease. Curr Eye Res. 2004;29(4–5):235–243. doi:10.1080/02713680490516738
- Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet’s disease. Invest Ophthalmol Vis Sci. 1998;39(6):996–1004.
- Tsuji-Yamada J, Nakazawa M, Minami M, Saeki T. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis. J Rheumatol. 2001;28(6):1252–1258.
- Lu CY, Lin JM, Chen YY, Chen YC. Building-related symptoms among office employees associated with indoor carbon dioxide and total volatile organic compounds. Int J Environ Res Public Health. 2015;12(6):5833–5845. doi:10.3390/ijerph120605833
- Miyajima E, Tsunoda M, Sugiura Y, et al. The diagnosis of sick house syndrome: the contribution of diagnostic criteria and determination of chemicals in an indoor environment. Tokai J Exp Clin Med. 2015;40(2):69–75.
- BenEzra D. Guidelines on the diagnosis and treatment of conjunctivitis. Ocul Immunol Inflamm. 1994;2(suppl):17–26.
- Uchio E, Kimura R, Migita H, Kozawa M, Kadonosono K. Demographic aspects of allergic conjunctival diseases and evaluation of new criteria for clinical assessment of ocular allergy. Graefes Arch Clin Exp Ophthalmol. 2008;246(2):291–296. doi:10.1007/s00417-007-0697-z
- Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol. 1988;140(12):4193–4198.
- Sahlberg B, Norbäck D, Wieslander G, Gislason T, Janson C. Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002. Indoor Air. 2012;22(4):331–338. doi:10.1111/j.1600-0668.2012.00766.x
- Benson M, Strannegård IL, Wennergren G, Strannegård O. Low levels of interferon-gamma in nasal fluid accompany raised levels of T-helper 2 cytokines in children with ongoing allergic rhinitis. Pediatr Allergy Immunol. 2000;11(1):20–28. doi:10.1034/j.1399-3038.2000.00051.x
- Glück J, Rogala B, Mazur B. Intracellular production of IL-2, IL-4 and IFN-gamma by peripheral blood CD3+ cells in intermittent allergic rhinitis. Inflamm Res. 2005;54(2):91–95. doi:10.1007/s00011-004-1328-3
- Leonardi A, Fregona IA, Plebani M, Secchi AG, Calder VL. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1240–1245. doi:10.1007/s00417-006-0285-7
- Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology. 2003;110:487–492. doi:10.1016/S0161-6420(02)01767-0
- Leonardi A, Cortivo R, Fregona IA, Plebani M, Secchi AG, Abatangelo G. The effects of Th2 cytokines on collagen, MMP-1 and TIMP-1 expression in conjunctival fibroblasts. Invest Ophthalmol Vis Sci. 2003;44(1):183–189. doi:10.1167/iovs.02-0420
- Lee MH, Lee BH, Shin HS, Lee MO. Elevated levels of PDGF receptor and MDM2 as potential biomarkers for formaldehyde intoxication. Toxicol Res. 2008;24(1):45–49. doi:10.5487/TR.2008.24.1.045
- Brouwer DH, De Pater NA, Zomer C, Lurvink MW, van Hemmen JJ. An experimental study to investigate the feasibility to classify paints according to neurotoxicological risks: occupational air requirement (OAR) and indoor use of alkyd paints. Ann Occup Hyg. 2005;49(5):443–451. doi:10.1093/annhyg/mei007